H. Lee Moffitt Cancer Licenses Rosetta's Resolver

Dec 04, 2006

NEW YORK (GenomeWeb News) — The H. Lee Moffitt Cancer and Research Institute has licensed Rosetta Biosoftware’s Resolver software, Rosetta said today.

The Moffitt Institute, based in Tampa, Fla., will use the software to handle and analyze data generated by the Total Cancer Care program to help identify cancer biomarkers.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Out of the Books

NPR reports that Turkish high school students will no longer study evolution.

Mountainside Sequencing

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

Better Treatments Sought

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

This Week in PNAS

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Main menu